Life Science REIT Income Statement

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Rental Revenue	15.94	15.48	13.12	1.28
Other Revenue	4.18	4.46	2.58	-
Total Revenue	20.12	19.94	15.71	1.28
Revenue Growth (YoY	4.25%	26.97%	1130.11%	-
Property Expenses	5.61	6.12	4.77	-
Selling, General & Administrative	5.08	5.25	5.61	2
Total Operating Expenses	10.69	11.37	10.38	2
Operating Income	9.43	8.58	5.33	-0.72
Interest Expense	-10.29	-9.6	-3.78	-
Interest & Investment Income	4.01	3.66	1.1	0.02
Other Non-Operating Income	-0.37	0.15	2.16	-
EBT Excluding Unusual Items	2.79	2.78	4.8	-0.71
Gain (Loss) on Sale of Assets	-0.32	-0.32	-	-
Asset Writedown	-41.3	-22.85	-31.31	19.29
Other Unusual Items	-1.46	-1.47	-0.96	-
Pretax Income	-40.29	-21.85	-27.47	18.58
Income Tax Expense	-0.25	-0.15	0.15	-
Net Income	-40.04	-21.71	-27.61	18.58
Net Income to Common	-40.04	-21.71	-27.61	18.58
Basic Shares Outstanding	350	350	350	350
Diluted Shares Outstanding	350	350	350	350
EPS (Basic)	-0.11	-0.06	-0.08	0.05
EPS (Diluted)	-0.11	-0.06	-0.08	0.05
Dividend Per Share	0.020	0.020	0.040	-
Dividend Growth	-50.00%	-50.00%	-	-
Operating Margin	46.87%	43.00%	33.93%	-56.77%
Profit Margin	-198.99%	-108.85%	-175.81%	1455.08%
Free Cash Flow Margin	58.52%	38.19%	-6.93%	665.04%
EBIT	9.43	8.58	5.33	-0.72
EBIT Margin	46.87%	43.00%	33.93%	-56.77%
Revenue as Reported	20.12	19.94	15.71	1.28

Source: S&P Capital IQ. Real Estate template. Financial Sources.